Document is current

Any future updates will be listed below

Metformin provides superior neuroprotective potential compared to semaglutide in preventing diabetes-associated Alzheimer’s disease via dual actions

Crossref DOI link: https://doi.org/10.1038/s43856-026-01471-3

Published Online: 2026-02-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark